COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,549 Articles (22,400 medRxiv, 8,149 bioRxiv)

Most recent first Previous |  Page 708: Articles 7071-7080  | Next

Reduced Exercise Capacity, Chronotropic Incompetence, Inflammation and Symptoms in Post-Acute COVID-19
Durstenfeld, M. S., Peluso, M. J., Kaveti, P., Hill, C., Li, D., Sander, E., Swaminathan, S., Arechiga, V. M., Sun, K., Sun, K., Ma, Y., Zepeda, V., Lu, S., Goldberg, S. A., Hoh, R., Win, S., Kelly, J. D., Henrich, T. J., Martin, J. N., Lee, Y. J., Aras, M. A., Long, C. S., Grandis, D. J., Deeks, S. G., Hsue, P. Y.
10.1101/2022.05.17.22275235 — Posted: 2022-05-19
Sequence Proven Reinfections with SARS-CoV-2 at a Large Academic Center
Morris, C. P., Eldesouki, R. E., Fall, A., Gaston, D. C., Norton, J. M., Gallagher, N., Luo, C. H., Abdullah, O., Klein, E. Y., Mostafa, H. H.
10.1101/2022.05.17.22275210 — Posted: 2022-05-19
Evaluation of anti-spike glycoprotein antibody and neutralizing antibody response of different vaccine platforms. A protocol of systematic review and meta-analysis of COVID-19 vaccine clinical trial studies
Mirzakhani, M., Tahmasebi, S., Dashti, M., Mohammadi, M. R., Faghih, M., Mohammadnia-Afrouzi, M., Esmaeili Gouvarchin Ghaleh, H., Amani, J.
10.1101/2022.05.18.22275247 — Posted: 2022-05-19
Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients.
Laham, G., Martinez, A. P., Rojas Gimenez, W., Amaya, L., Abib, A., Echegoyen, N., Diaz, C., Lucero, A., Martelli, A., Videla, C., Neukam, K., Di Lello, F. A.
10.1101/2022.05.13.22275049 — Posted: 2022-05-19
Clinical validation of 3D-printed nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 RT-PCR
Riis, A. G., Rossland, T. M., Löhr, I. H., Dalen, I., Kleppe, L. K., Sundal, J., Berg, A., Vadla, M. S., Lenning, O. B., Syre, H.
10.1101/2022.05.16.22274315 — Posted: 2022-05-19
Neutralization Escape by the SARS-CoV-2 Omicron Variants BA.2.12.1 and BA.4/BA.5
Hachmann, N., Miller, J., Collier, A.-r., Ventura, J., Yu, J., Rowe, M., Bondzie, E., Powers, O., Surve, N., Hall, K., Barouch, D. H.
10.1101/2022.05.16.22275151 — Posted: 2022-05-19
Fear of Infection and Sufficient Vaccine Reservation Information Might Drive Rapid Coronavirus Disease 2019 Vaccination in Japan: Evidence from Twitter Analysis
Niu, Q., Liu, J., Kato, M., Aoyama, T., Nagai-Tanima, M.
10.1101/2022.05.15.22275071 — Posted: 2022-05-19
COVID-19 booster dose antibody response in pregnant, lactating, and nonpregnant women
Atyeo, C., Shook, L. L., Nziza, N., DeRiso, E. A., Muir, C., Medina Baez, A., Lima, R. S., Demidkin, S., Brigida, S., De Guzman, R. M., Burns, M. D., Balazs, A. B., Fasano, A., Yonker, L. M., Gray, K. J., Alter, G., Edlow, A. G.
10.1101/2022.05.17.22275154 — Posted: 2022-05-19
Self-medication practices and associated factors among COVID-19 recovered patients to prevent future infections: A web-based survey in Bangladesh
Sujan, M. S. H., Haghighathoseini, A., Tasnim, R., Islam, M. S., Salauddin, S. M., Hasan, M. M., Uddin, M. R.
10.1101/2022.05.14.22275075 — Posted: 2022-05-19
Reduced antibody acquisition with increasing age following vaccination with BNT162b2: results from a large study performed in the general population aged 12 to 92 years
van den Hoogen, L. L., Boer, M. C., Postema, A., de Rond, L., de Zeeuw-Brouwer, M.-l., Pronk, I., Wijmenga-Monsuur, A. J., Bijvank, E., Kruiper, C., Beckers, L., Bogaard-van Maurik, M., Zutt, I., van Vliet, J., van Bergen, R., Kuijer, M., Smits, G., Verschuren, W. M. M., Picavet, H. S. J., van der Klis, F. R. M., den Hartog, G., van Binnendijk, R. S., Buisman, A.-M.
10.1101/2022.05.18.22275209 — Posted: 2022-05-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).